Vera Therapeutics is a clinical-stage biotechnology company focused on developing and commercializing transformative treatments for patients with serious immunological diseases. The company's lead product candidate, atacicept, is a fusion protein that targets B-cell activating factor (BAFF) and a proliferation-inducing ligand (APRIL), which are members of the tumor necrosis factor (TNF) superfamily. Atacicept has the potential to address a broad range of autoimmune and inflammatory diseases, including primary IgA nephropathy, a rare kidney disease with no approved therapies. Vera Therapeutics is headquartered in San Bruno, California.
Highest paying job titles at Vera Therapeutics, Inc. include Medical Director, Senior Scientist, and Chief Technology Officer (CTO)